Compound ID | 252

Update compound information

NBTI 5463

Class: Bacterial topoisomerase inhibitor

Spectrum of activity: Gram-negative
Details of activity: A novel bacterial type II topoisomerase inhibitor, NBTI 5463, with activity against gram-negative pathogens
Propensity to select resistant mutants: No (demonstrated high resistance)
Institute where first reported: AstraZeneca - UK
Year first mentioned: 2014
Highest developmental phase: Preclinical
Development status: Active
Chemical structure(s):
Click here for structure editor
Molecular weight: 478.54
Iso. SMILES: COC1=CC2=C(C=CC(=O)N2C[C@@H](C3CCC(CC3)NCC4=NC5=C(C=C4)OCC(=O)N5)N)N=C1
InChI Key: HXCSDXBLCTUKEB-RJYAGPCLSA-N
Can. SMILES: COC1=CN=C2C=CC(=O)N(C[C@@H](C3CCC(CC3)NCC4=CC=C5C(=N4)NC(=O)CO5)N)C2=C1
InChI: InChI=1S/C25H30N6O4/c1-34-18-10-21-20(28-12-18)7-9-24(33)31(21)13-19(26)15-2-4-16(5-3-15)27-11-17-6-8-22-25(29-17)30-23(32)14-35-22/h6-10,12,15-16,19,27H,2-5,11,13-14,26H2,1H3,(H,29,30,32)/t15?,16?,19-/m0/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/46205341
Citations:
  • http://aac.asm.org/content/58/5/2657.full
  • http://aac.asm.org/content/59/1/331.full

  • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.